AVMA news
Conference of Research Workers in Animal Diseases – January 20-24, 2023
The Conference of Research Workers in Animal Diseases (CRWAD) held its annual conference from January 20-24 in Chicago. The CRWAD presented awards,…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
AVMA editor-in-chief becomes Equine Research Hall of Famer, with three others
AVMA Editor-In-Chief Lisa Fortier along with Drs. Katrin Hinrichs, Jennifer Anne Mumford, and Stephen M. Reed are this year’s inductees into the…
JAVMA news
Webinar explains federal guidance on manufacturing of animal cells and tissues
The Food and Drug Administration posted a prerecorded webinar this fall explaining draft guidance documents on good manufacturing practices and donor…
JAVMA news
Academic groups seek easier approval path for gene-edited food animals
Two academic groups argue that the amount of regulatory oversight for genetic changes in food animals should depend on the nature of the changes, and…
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…
JAVMA news
FDA offers listings of clinical studies in regenerative medicine
In February, agency officials began populating a site with information on clinical studies involving the use of animal cells, tissues, and cell- and…
JAVMA news
Racing to save humans through animal research
Veterinary researchers are improving our understanding of the SARS-CoV-2 virus, interspecies transmission, and a host of other public and animal…
JAVMA news
Longtime canine epilepsy treatment gains conditional approval
Food and Drug Administration officials granted conditional approval of a chewable potassium bromide tablet, KBroVet-CA1, for the control of seizures…
JAVMA news
NIH funds development of novel Lyme disease vaccine
The grant is funding the efforts of tick immunobiologist Utpal Pal, PhD, to adapt the rabies vaccination platform to stimulate production of…
JAVMA news
Veterinary faculty among 2019 elected AAAS fellows
Three faculty at U.S. veterinary colleges are among 443 fellows chosen this past year by the American Association for the Advancement of Science. The…
JAVMA news
The continuing conundrum of feline injection-site sarcomas
Veterinarians would much rather talk with cat owners about all the advantages of vaccination for cats rather than the extremely rare occurrence of…
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
AAHA releases new guidelines on canine vaccination
The American Animal Hospital Association announced Sept. 5 that it has released new guidelines on canine vaccination.
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
JAVMA news
Dog monitor taken off the market
A wearable electronic device intended for use on dogs is no longer available, as enrollment in its veterinary monitoring program was slower
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…